Rethinking Unmet Patient Medical Needs Through the Lens of the Patient Journey

This article was published in the Pharmaceutical Executive which can be accessed via https://www.pharmexec.com/view/rethinking-unmet-patient-medical-needs-through-the-lens-of-the-patient-journey

Overview

This article offers insights into how biopharma companies can foster patient-centered innovation by focusing on unmet needs along each stage of the patient journey while collaborating with key stakeholders directly or indirectly responsible for disease management.

• The unmet patient needs continue to prevail in virtually every disease

• Stakeholder perceptions of unmet needs tend to vary across diseases

• The unmet patient needs vary across acute vs. chronic conditions

• Uncovering unmet patient needs requires closely following the patient's journey

• Unmet needs are central to patient-centric innovation and value creation

Authors

• Subbarao Jayanthi, Managing Partner of RxC International

• LizAnn Sung, Mangement Consultant at RxC International

About RXC International

RxC International is a premier biopharma strategy consulting firm helping clients with growth strategies. The firm has deep expertise in new product planning and commercialization strategy. Our clients include leading pharmaceutical and biotechnology companies around the world. The firm has offices in New Jersey, Massachusetts, and California. Additional information about RxC International is available at www.RxCInternational.com.

If you have any questions or need additional information, please contact us at info@RxCinternational.com

Featured in the Pharmaceutical Executive in April 2023

Text